E. Zuckerman

1.9k total citations
30 papers, 1.1k citations indexed

About

E. Zuckerman is a scholar working on Hepatology, Epidemiology and Rheumatology. According to data from OpenAlex, E. Zuckerman has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 7 papers in Epidemiology and 7 papers in Rheumatology. Recurrent topics in E. Zuckerman's work include Hepatitis C virus research (12 papers), Systemic Lupus Erythematosus Research (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). E. Zuckerman is often cited by papers focused on Hepatitis C virus research (12 papers), Systemic Lupus Erythematosus Research (4 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers). E. Zuckerman collaborates with scholars based in Israel, United States and Australia. E. Zuckerman's co-authors include Daniel Yeshurun, Jochanan E. Naschitz, Gleb Slobodin, Roger Lewis, Michael Rozenbaum, Elias Toubi, Michael P. Manns, Christian Rust, Ulrich Spengler and Wolfgang Kreisel and has published in prestigious journals such as Blood, Gastroenterology and Hepatology.

In The Last Decade

E. Zuckerman

29 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Zuckerman Israel 13 647 556 230 214 111 30 1.1k
Michéle Moretti Italy 17 448 0.7× 391 0.7× 98 0.4× 145 0.7× 136 1.2× 39 1.3k
Luigi Iannaccone Italy 13 582 0.9× 379 0.7× 311 1.4× 366 1.7× 73 0.7× 30 1.1k
Cumali Efe Türkiye 19 616 1.0× 628 1.1× 169 0.7× 319 1.5× 23 0.2× 59 954
Maria Grazia Alessio Italy 19 127 0.2× 477 0.9× 119 0.5× 357 1.7× 29 0.3× 57 1.1k
Gloria de la Red Spain 13 262 0.4× 188 0.3× 398 1.7× 158 0.7× 15 0.1× 17 874
Jean Bernard Otte Belgium 18 574 0.9× 309 0.6× 44 0.2× 747 3.5× 88 0.8× 28 1.2k
F. Domont France 16 266 0.4× 306 0.6× 403 1.8× 107 0.5× 40 0.4× 34 1.2k
Liang-Tsai Hsiao Taiwan 15 291 0.4× 400 0.7× 43 0.2× 59 0.3× 53 0.5× 50 894
F. Mal France 12 492 0.8× 275 0.5× 112 0.5× 301 1.4× 12 0.1× 24 878
Domenico Facciorusso Italy 18 610 0.9× 543 1.0× 77 0.3× 327 1.5× 12 0.1× 32 1.0k

Countries citing papers authored by E. Zuckerman

Since Specialization
Citations

This map shows the geographic impact of E. Zuckerman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Zuckerman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Zuckerman more than expected).

Fields of papers citing papers by E. Zuckerman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Zuckerman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Zuckerman. The network helps show where E. Zuckerman may publish in the future.

Co-authorship network of co-authors of E. Zuckerman

This figure shows the co-authorship network connecting the top 25 collaborators of E. Zuckerman. A scholar is included among the top collaborators of E. Zuckerman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Zuckerman. E. Zuckerman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dufour, Jean‐François, E. Zuckerman, Neddie Zadeikis, et al.. (2017). Safety of glecaprevir/pibrentasvir in adults with chronic genotype 1–6 hepatitis C virus infection: an integrated analysis. Journal of Hepatology. 66(1). S515–S515. 9 indexed citations
2.
Gane, Edward, Ziv Ben Ari, Lindsay Mollison, et al.. (2016). Efficacy and safety of grazoprevir + ribavirin for 12 or 24 weeks in treatment‐naïve patients with hepatitis C virus genotype 1 infection. Journal of Viral Hepatitis. 23(10). 789–797. 9 indexed citations
3.
Kessel, Aharon, Itzhak Rosner, E. Zuckerman, Theo Dov Golan, & Elias Toubi. (2011). Use of antikeratin antibodies to distinguish between rheumatoid arthritis and polyarthritis associated with hepatitis C infection. Reumatismo. 53(2).
4.
Manns, Michael P., Marek Woynarowski, Wolfgang Kreisel, et al.. (2010). Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis. Gastroenterology. 139(4). 1198–1206. 258 indexed citations
5.
Toubi, Elias, Stuart C. Gordon, Aharon Kessel, et al.. (2006). Elevated serum B-Lymphocyte activating factor (BAFF) in chronic hepatitis C virus infection: Association with autoimmunity. Journal of Autoimmunity. 27(2). 134–139. 97 indexed citations
6.
Naschitz, Jochanan E., Itzhak Rosner, Michael Rozenbaum, et al.. (2004). Patterns of cardiovascular reactivity in disease diagnosis. QJM. 97(3). 141–151. 23 indexed citations
7.
Slobodin, Gleb, Itzhak Rosner, Michael Rozenbaum, et al.. (2002). Systemic sclerosis sine scleroderma: is it always the same disease? Report of three patients and discussion. Rheumatology International. 22(4). 170–172. 11 indexed citations
8.
9.
Slobodin, Gleb, Itzhak Rosner, Michael Rozenbaum, et al.. (2000). Systemic sclerosis sine scleroderma: Comment on the article by Poormoghim et al. Arthritis & Rheumatism. 43(11). 2618–2618. 2 indexed citations
10.
Naschitz, Jochanan E., Gleb Slobodin, Roger Lewis, E. Zuckerman, & Daniel Yeshurun. (2000). Heart diseases affecting the liver and liver diseases affecting the heart. American Heart Journal. 140(1). 111–120. 197 indexed citations
11.
Zuckerman, E., Dean Keren, Michael Rozenbaum, et al.. (2000). Hepatitis C virus-related arthritis: characteristics and response to therapy with interferon alpha.. PubMed. 18(5). 579–84. 66 indexed citations
12.
Gaitini, Luis, et al.. (2000). In-field validation of automatic blood pressure measuring devices. Journal of Human Hypertension. 14(1). 37–42. 16 indexed citations
13.
Naschitz, Jochanan E., et al.. (1995). Case Report: Extensive Pulmonary and Aortic Thrombosis and Ectasia. The American Journal of the Medical Sciences. 310(1). 34–37. 1 indexed citations
14.
Zuckerman, E., et al.. (1994). FASCIITIS‐PANNICULITIS IN ACUTE BRUCELLOSIS. International Journal of Dermatology. 33(1). 57–59. 10 indexed citations
15.
Naschitz, Johanan E., Daniel Yeshurun, E. Zuckerman, et al.. (1994). Cancer-associated fasciitis panniculitis. Cancer. 73(1). 231–235. 53 indexed citations
16.
Zuckerman, E., et al.. (1994). Spontaneous Perinephric Hemorrhage in a Middle-Aged Diabetic Woman. The Journal of Urology. 151(4). 977–979. 9 indexed citations
17.
Yeshurun, Daniel, et al.. (1992). The fasciitis-panniculitis syndrome: Clinical spectrum and response to cimetidine. Seminars in Arthritis and Rheumatism. 21(4). 211–220. 27 indexed citations
18.
Shechner, Carmela, Zaki Kraiem, E. Zuckerman, & Gabriel Dickstein. (1992). Toxic Graves' Disease with Thyroid Hemiagenesis: Diagnosis Using Thyroid-Stimulating Immunoglobulin Measurements. Thyroid. 2(2). 133–135. 18 indexed citations
19.
Naschitz, Johanan E., et al.. (1992). Case Report: Lymphadenopathy, Perinodal Granulomatosis, and Immunologic Aberrations. The American Journal of the Medical Sciences. 304(4). 254–257. 2 indexed citations
20.
Nagler, A, et al.. (1988). Acute respiratory failure in hyperleukocytotic acute myeloid leukemia: The role of perfusion lung scintigraphy. American Journal of Hematology. 27(1). 65–66. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michéle Moretti Breakdown of academic impact, for papers by Luigi Iannaccone Breakdown of academic impact, for papers by Cumali Efe Breakdown of academic impact, for papers by Maria Grazia Alessio Breakdown of academic impact, for papers by Gloria de la Red Breakdown of academic impact, for papers by Jean Bernard Otte Breakdown of academic impact, for papers by F. Domont Breakdown of academic impact, for papers by Liang-Tsai Hsiao Breakdown of academic impact, for papers by F. Mal Breakdown of academic impact, for papers by Domenico Facciorusso
Rankless by CCL
2026